Cargando…

Tayloring cell populations for neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	Fortin, Jeff M., Deleyrolle, Loic P., Reynolds, Brent A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116835/ https://www.ncbi.nlm.nih.gov/pubmed/27904487 http://dx.doi.org/10.4103/1673-5374.193235

Ejemplares similares

Transplantation of Defined Populations of Differentiated Human Neural Stem Cell Progeny
por: Fortin, Jeff M., et al.
Publicado: (2016)

Ros Taylor: seeing palliative care as relational
por: Samarasekera, Udani
Publicado: (2022)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Human endogenous retroviruses: ammunition for myeloid cells in neurodegenerative diseases?
por: Gruchot, Joel, et al.
Publicado: (2019)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases
por: Hellmers, Natalie, et al.
Publicado: (2016)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

A perspective on age-related changes in cell environment and risk of neurodegenerative diseases
por: Liu, Alice Y.
Publicado: (2023)

Beneficial effects of date palm fruits on neurodegenerative diseases
por: Essa, Musthafa Mohamed, et al.
Publicado: (2016)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Role of myelin sheath energy metabolism in neurodegenerative diseases
por: Ravera, Silvia, et al.
Publicado: (2015)

Tubulin glutamylation: a skeleton key for neurodegenerative diseases
por: van der Laan, Siem, et al.
Publicado: (2019)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Can foods influence the onset and progress of neurodegenerative diseases?
por: Piemontese, Luca, et al.
Publicado: (2022)

Brain-derived neurotrophic factor in main neurodegenerative diseases
por: Camuso, Serena, et al.
Publicado: (2022)

Targeting glial metabolism in neurodegenerative diseases: detail matters
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Why use pre-differentiated cells to address complex multi-factorial neurodegenerative diseases?
por: Kopyov, Alex, et al.
Publicado: (2020)

How does resveratrol influence the genesis of some neurodegenerative diseases?
por: Tellone, Ester, et al.
Publicado: (2016)

Paracrine factors for neurodegenerative disorders: special emphasis on Parkinson's disease
por: Di Santo, Stefano, et al.
Publicado: (2016)

A substrate scaffold for assessment of nerve regeneration and neurodegenerative diseases
por: Chen, Wei-Hsin, et al.
Publicado: (2015)

The emerging epigenetics of PARK7 and its implication in neurodegenerative disease
por: Vavougios, George D., et al.
Publicado: (2018)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
por: Duan, Yanhui, et al.
Publicado: (2020)

Potential of kynurenine metabolites in drug development against neurodegenerative diseases
por: Kubicova, Lenka, et al.
Publicado: (2020)

hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible
por: Rivetti di Val Cervo, Pia, et al.
Publicado: (2021)

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases
por: Maneu, Victoria, et al.
Publicado: (2021)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

Glial interference: impact of type I interferon in neurodegenerative diseases
por: Roy, Ethan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t48hbt4t6v5cfucbe1mqaj5jla